Sunitinib-induced hypertension: close monitoring required Clinical study 19 January 2013 Pages: 1 - 1
The Canadian Adverse Drug Reaction Monitoring Program has been renamed as Canada Vigilance News item 19 January 2013 Pages: 2 - 2
Two more studies addressing risks with epoetins reported to FDA Media release 19 January 2013 Pages: 3 - 3
Young women in early menopause who receive hormone replacement therapy (HRT) do not appear to have increased risks for cardiovascular disorders Media release 19 January 2013 Pages: 4 - 4
Tighter controls for ephedrine and pseudoephedrine contained in nasal decongestants will become law from 1 April 2008 Media release 19 January 2013 Pages: 4 - 4
Following the withdrawal from all European Union Member States,* lumiracoxib [Prexige] has now been withdrawn from the New Zealand market Media release 19 January 2013 Pages: 4 - 4
Low-dose aspirin appears to be associated with the premature discontinuation of flutamide due to abnormal liver function tests News item 19 January 2013 Pages: 5 - 5
Rosuvastatin concentrations increased with lopinavir/ritonavir News item 19 January 2013 Pages: 5 - 5
The use of fibric acid derivatives combined with rosiglitazone appears to decrease HDL cholesterol levels in patients with diabetes mellitus (DM) News item 19 January 2013 Pages: 5 - 5
